Catalyst Wire Dossier Catalyst Wire Dossier

MITIGARE

Colchicine · Hikma Specialty USA Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MITIGARE, covering 2014-09-26 to 2024-05-16. Get the full timeline:

Most recent: FDA Approved: MITIGARE — Supplemental Application (Hikma Specialty USA Inc.)

See pricing